Strides Pharma Science Ltd reported a consolidated net profit of Rs 10.44 crore for Q4 ending March 2024, reversing a net loss of Rs 13.79 crore a year ago. The company also announced significant top management changes and achieved its highest-ever annual revenue, driven by growth in the US market.
Bank of Cyprus
will be reviewing its 2024 profit targets following a strong
start to the year reflected in first-quarter earnings, its CEO
said in an interview. The bank last week posted.
Niger Delta leaders applaud NDDC for rural electrification, other projects thenationonlineng.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationonlineng.net Daily Mail and Mail on Sunday newspapers.